Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ Richter's Syndrome
Richter's Syndrome
8 registered clinical trials studyying Richter's Syndrome.
Status
Trial
Sponsor
Phase
Completed
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R
NCT05665530
Prelude Therapeutics
Phase 1
Completed
A Study to Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome;
NCT04939363
Bnai Zion Medical Center
Phase 2
Active Not Recruiting
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and
NCT04623541
Genmab
Phase 1 / Phase 2
Completed
Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter
NCT03113695
University of California, San Diego
Phase 1
Completed
Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractor
NCT03263637
AstraZeneca
Phase 1
Completed
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
NCT02362035
Acerta Pharma BV
Phase 1 / Phase 2
Active Not Recruiting
ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic
NCT02029443
Acerta Pharma BV
Phase 1 / Phase 2
Completed
Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Ri
NCT01171378
University of Oxford
Phase 2